Don’t miss this opportunity to connect with THE cannabis movers and shakers from across the globe during Benzinga’s Virtual Cannabis Capital Conference on October 15. Among the attendees is Cannaphyll.
Cannaphyll is a wellness brand that specializes in hemp-infused body-care products, with its hero product being its infused topical cream.
Cannaphyll Infused Topical Cream is the highest-potency hemp-infused topical product sold over the counter in America, with 1000mg of hemp extract in every ounce. Cannaphyll is currently available in the US and UK through Amazon.com, Inc. (NASDAQ:AMZN), as well as doctors’ offices and retailers nationwide.
Cannaphyll’s patent-pending formula has been scientifically proven to enhance and accelerate cannabinoid bioavailability. Organic ingredients such as elderberry, neroli, and lavender, known for their antioxidant, anti-inflammatory and antibacterial properties, work synergistically with cannabinoids to powerfully and effectively penetrate skin, muscles, nerves, and joints.
Cofounder Kim Clark created Cannaphyll’s original, whole-plant formula in 2011 to provide palliative care for her terminally ill mother and Cannaphyll namesake, Phyllis, who credited cannabis with extending and improving her final years.
Cannaphyll Infused Topical Gel will be released this fall, along with four dozen other products scheduled for release over the next two years. These new releases will include infused body essentials, arousal gels, hair revitalizers, topical antiseptics, and many others.
CEO of Cannaphyll, Jude Bond, will be presenting at the upcoming Benzinga Cannabis Capital Conference to provide an overview of the company and its products, as well as to discuss investment opportunities in Cannaphyll.
To learn more about Cannaphyll, you can sign up for the Benzinga Cannabis Capital Conference by clicking here.
© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.